Overexpression of cancerous inhibitor ofPP2A ( CIP2A ) in acute myeloid leukemia.
Reem HasaninGhada MossallamSally ElfishawiAhmed RabeaNayera HamdyPublished in: Expert review of hematology (2022)
overexpression is a useful prognostic marker in AML.